Symbols / MCTA $29.36 +0.00%
MCTA Chart
About
Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health. In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. Further, the company's products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Care Facilities | Market Cap | 504.26M |
| Enterprise Value | 448.65M | Income | 1.20M | Sales | 6.22M |
| Book/sh | 0.00 | Cash/sh | 0.18 | Dividend Yield | — |
| Payout | 0.00% | Employees | 49 | IPO | — |
| P/E | 419.36 | Forward P/E | — | PEG | — |
| P/S | 81.05 | P/B | 9785.00 | P/C | — |
| EV/EBITDA | 240.81 | EV/Sales | 72.11 | Quick Ratio | 0.64 |
| Current Ratio | 0.68 | Debt/Eq | 2356.96 | LT Debt/Eq | — |
| EPS (ttm) | 0.07 | EPS next Y | — | EPS Growth | 81.00% |
| Revenue Growth | -3.30% | Earnings | — | ROA | 19.53% |
| ROE | — | ROIC | — | Gross Margin | 96.76% |
| Oper. Margin | 28.86% | Profit Margin | 19.27% | Shs Outstand | 15.18M |
| Shs Float | 4.31M | Short Float | 14.39% | Short Ratio | — |
| Short Interest | — | 52W High | 31.70 | 52W Low | 4.30 |
| Beta | — | Avg Volume | 0.00 | Volume | 0.00 |
| Target Price | — | Recom | None | Prev Close | $29.36 |
| Price | $29.36 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$29.36
Latest analyst target
3. DCF / Fair value
$1.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$29.36
Low
—
High
—
Mean
—
- Investors who lost money with Charming Medical Limited (NASDAQ: MCTA) should contact the Shareholders Foundation in connection with Lawsuit - Morningstar ue, 03 Feb 2026 08
- Shareholders who lost money in shares Charming Medical Ltd. (NASDAQ: MCTA) Should Contact Wolf Haldenstein Immediately - PR Newswire Wed, 07 Jan 2026 08
- Law Offices of Frank R. Cruz Encourages Charming Medical Limited (MCTA) Shareholders To Inquire About Securities Fraud Class Action - Business Wire Wed, 24 Dec 2025 08
- MCTA Stockholders with Large Losses Should Contact Robbins - GlobeNewswire Mon, 29 Dec 2025 08
- Chinese Stocks To Consider - March 14th - MarketBeat Sat, 14 Mar 2026 16
- Charming Medical (MCTA) Faces Class Action Over Alleged Stock Price Manipulation - Intellectia AI ue, 20 Jan 2026 08
- Nasdaq halts trading of Charming Medical after SEC suspension - Investing.com Wed, 26 Nov 2025 08
- DEADLINE ALERT for FFIV, SLM, MCTA, and KLAR: The Law - GlobeNewswire ue, 17 Feb 2026 08
- Deadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire hu, 12 Feb 2026 08
- MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm - Morningstar Mon, 05 Jan 2026 08
- Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA) - Business Wire Mon, 05 Jan 2026 08
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Charming Medical Limited (MCTA) Shareholders to Inquire About Securities Fraud Class Action - Business Wire Fri, 26 Dec 2025 08
- Charming Medical prices IPO at $4 per share for NASDAQ listing - Investing.com ue, 21 Oct 2025 07
- Charming Medical Faces Trading Suspension Amid SEC Investigation - TipRanks hu, 13 Nov 2025 08
- SEC orders trading in Charming Medical securities be suspended - TipRanks Wed, 12 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 429.84 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.16 | 0.18 | 0.20 |
| NormalizedEBITDA | 1.72M | 1.42M | -189.13K |
| TotalUnusualItems | 2.62K | ||
| TotalUnusualItemsExcludingGoodwill | 2.62K | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | 1.20M | 777.81K | -305.12K |
| ReconciledDepreciation | 263.45K | 391.70K | 211.08K |
| ReconciledCostOfRevenue | 2.04M | 2.10M | 2.04M |
| EBITDA | 1.72M | 1.42M | -189.13K |
| EBIT | 1.46M | 1.03M | -400.21K |
| NetInterestIncome | -167.43K | -170.25K | -152.28K |
| InterestExpense | 20.87K | 26.05K | 20.26K |
| InterestIncome | 64.14K | 19.51K | 10.29K |
| NormalizedIncome | 1.20M | 777.81K | -305.12K |
| NetIncomeFromContinuingAndDiscontinuedOperation | 1.20M | 777.81K | -305.12K |
| TotalExpenses | 4.61M | 4.84M | 3.82M |
| RentExpenseSupplemental | 711.72K | 848.69K | 647.62K |
| TotalOperatingIncomeAsReported | 1.39M | 1.01M | -521.34K |
| DilutedAverageShares | 16.94M | 16.94M | |
| BasicAverageShares | 16.94M | 16.94M | |
| DilutedEPS | 0.05 | -0.02 | |
| BasicEPS | 0.05 | -0.02 | |
| DilutedNIAvailtoComStockholders | 1.20M | 777.81K | -305.12K |
| NetIncomeCommonStockholders | 1.20M | 777.81K | -305.12K |
| NetIncome | 1.20M | 777.81K | -305.12K |
| MinorityInterests | 0.00 | -43.93K | 30.49K |
| NetIncomeIncludingNoncontrollingInterests | 1.20M | 821.74K | -335.61K |
| NetIncomeContinuousOperations | 1.20M | 821.74K | -335.61K |
| TaxProvision | 236.08K | 181.75K | -84.86K |
| PretaxIncome | 1.44M | 1.00M | -420.47K |
| OtherIncomeExpense | -12.52K | -214.00 | 19.31K |
| OtherNonOperatingIncomeExpenses | -15.14K | -214.00 | 19.31K |
| GainOnSaleOfSecurity | 2.62K | ||
| NetNonOperatingInterestIncomeExpense | -167.43K | -170.25K | -152.28K |
| TotalOtherFinanceCost | 210.69K | 163.71K | 142.31K |
| InterestExpenseNonOperating | 20.87K | 26.05K | 20.26K |
| InterestIncomeNonOperating | 64.14K | 19.51K | 10.29K |
| OperatingIncome | 1.62M | 1.17M | -287.50K |
| OperatingExpense | 2.57M | 2.74M | 1.78M |
| OtherOperatingExpenses | -15.49K | -1.40K | -91.53K |
| DepreciationAmortizationDepletionIncomeStatement | 263.45K | 391.70K | 211.08K |
| DepreciationAndAmortizationInIncomeStatement | 263.45K | 391.70K | 211.08K |
| DepreciationIncomeStatement | 263.45K | 391.70K | 211.08K |
| SellingGeneralAndAdministration | 2.32M | 2.35M | 1.66M |
| SellingAndMarketingExpense | 999.35K | 859.47K | 664.88K |
| GeneralAndAdministrativeExpense | 1.32M | 1.49M | 996.95K |
| OtherGandA | 606.24K | 641.56K | 349.33K |
| RentAndLandingFees | 711.72K | 848.69K | 647.62K |
| GrossProfit | 4.18M | 3.91M | 1.49M |
| CostOfRevenue | 2.04M | 2.10M | 2.04M |
| TotalRevenue | 6.22M | 6.02M | 3.53M |
| OperatingRevenue | 6.22M | 6.02M | 3.53M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| OrdinarySharesNumber | 16.94M | 16.94M | 16.94M |
| ShareIssued | 16.94M | 16.94M | 16.94M |
| TotalDebt | 1.16M | 961.38K | 1.81M |
| TangibleBookValue | 49.24K | -1.08M | -1.16M |
| InvestedCapital | 363.47K | -636.83K | -568.95K |
| WorkingCapital | -1.58M | -2.21M | -3.05M |
| NetTangibleAssets | 49.24K | -1.08M | -1.16M |
| CapitalLeaseObligations | 846.41K | 518.77K | 1.22M |
| CommonStockEquity | 49.24K | -1.08M | -1.16M |
| TotalCapitalization | 49.24K | -1.08M | -1.16M |
| TotalEquityGrossMinorityInterest | 49.24K | -1.15M | -1.27M |
| MinorityInterest | 0.00 | -66.63K | -110.21K |
| StockholdersEquity | 49.24K | -1.08M | -1.16M |
| OtherEquityInterest | -381.04K | -381.04K | -381.04K |
| GainsLossesNotAffectingRetainedEarnings | -3.57K | 205.00 | 3.92K |
| OtherEquityAdjustments | -3.57K | 205.00 | 3.92K |
| RetainedEarnings | 119.44K | -1.08M | -1.16M |
| AdditionalPaidInCapital | 312.88K | 379.51K | 379.51K |
| CapitalStock | 1.53K | 1.53K | 1.53K |
| CommonStock | 1.53K | 1.53K | 1.53K |
| TotalLiabilitiesNetMinorityInterest | 5.31M | 6.03M | 7.65M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 358.03K | 148.25K | 484.26K |
| LongTermDebtAndCapitalLeaseObligation | 358.03K | 148.25K | 484.26K |
| LongTermCapitalLeaseObligation | 358.03K | 148.25K | 484.26K |
| CurrentLiabilities | 4.95M | 5.88M | 7.17M |
| CurrentDeferredLiabilities | 3.46M | 4.50M | 5.60M |
| CurrentDeferredRevenue | 3.46M | 4.50M | 5.60M |
| CurrentDebtAndCapitalLeaseObligation | 802.61K | 813.13K | 1.33M |
| CurrentCapitalLeaseObligation | 488.38K | 370.52K | 735.60K |
| CurrentDebt | 314.23K | 442.61K | 589.66K |
| LineOfCredit | 314.23K | 442.61K | 589.66K |
| PayablesAndAccruedExpenses | 682.41K | 570.40K | 240.88K |
| CurrentAccruedExpenses | 206.28K | 411.14K | 228.07K |
| Payables | 476.12K | 159.26K | 12.80K |
| OtherPayable | 36.70K | 40.01K | 11.23K |
| DuetoRelatedPartiesCurrent | 214.60K | 0.00 | |
| TotalTaxPayable | 221.34K | 119.25K | 0.00 |
| AccountsPayable | 3.48K | 0.00 | 1.57K |
| TotalAssets | 5.36M | 4.88M | 6.38M |
| TotalNonCurrentAssets | 1.99M | 1.21M | 2.26M |
| NonCurrentPrepaidAssets | 128.29K | 54.60K | 193.75K |
| NonCurrentDeferredAssets | 649.64K | 237.98K | 272.77K |
| NonCurrentDeferredTaxesAssets | 77.29K | 211.14K | 272.77K |
| NetPPE | 1.21M | 921.86K | 1.80M |
| AccumulatedDepreciation | -2.00M | -1.59M | -1.12M |
| GrossPPE | 3.21M | 2.51M | 2.92M |
| Leases | 724.40K | 798.53K | 752.41K |
| MachineryFurnitureEquipment | 659.47K | 369.27K | 201.91K |
| BuildingsAndImprovements | 1.83M | 1.34M | 1.97M |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 3.37M | 3.67M | 4.12M |
| Inventory | 26.80K | 28.15K | 66.33K |
| Receivables | 579.09K | 1.54M | 2.12M |
| OtherReceivables | 183.19K | 298.95K | 120.54K |
| DuefromRelatedPartiesCurrent | 0.00 | 885.06K | 1.82M |
| AccountsReceivable | 395.90K | 351.61K | 186.64K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | 0.00 | 0.00 |
| GrossAccountsReceivable | 395.90K | 351.61K | 186.64K |
| CashCashEquivalentsAndShortTermInvestments | 2.76M | 2.10M | 1.93M |
| OtherShortTermInvestments | 1.94M | 0.00 | |
| CashAndCashEquivalents | 816.77K | 2.10M | 1.93M |
| CashFinancial | 2.10M | 1.93M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| FreeCashFlow | 138.36K | 84.83K | 1.83M |
| RepaymentOfDebt | -156.94K | -154.19K | -177.92K |
| IssuanceOfDebt | 205.87K | 38.34K | 0.00 |
| CapitalExpenditure | -287.53K | -210.60K | -606.19K |
| InterestPaidSupplementalData | 20.87K | 26.05K | 20.26K |
| EndCashPosition | 816.77K | 2.10M | 1.93M |
| BeginningCashPosition | 2.10M | 1.93M | 1.53M |
| EffectOfExchangeRateChanges | -4.62K | -10.51K | 5.66K |
| ChangesInCash | -1.28M | 184.98K | 397.33K |
| FinancingCashFlow | 521.30K | 100.14K | -1.43M |
| CashFlowFromContinuingFinancingActivities | 521.30K | 100.14K | -1.43M |
| NetOtherFinancingCharges | 472.37K | 216.00K | -1.25M |
| NetIssuancePaymentsOfDebt | 48.93K | -115.85K | -177.92K |
| NetShortTermDebtIssuance | -130.78K | -148.88K | -177.92K |
| ShortTermDebtPayments | -130.78K | -148.88K | -177.92K |
| NetLongTermDebtIssuance | 179.71K | 33.03K | 0.00 |
| LongTermDebtPayments | -26.15K | -5.31K | 0.00 |
| LongTermDebtIssuance | 205.87K | 38.34K | 0.00 |
| InvestingCashFlow | -2.23M | -210.60K | -606.19K |
| CashFlowFromContinuingInvestingActivities | -2.23M | -210.60K | -606.19K |
| NetInvestmentPurchaseAndSale | -1.94M | 0.00 | |
| PurchaseOfInvestment | -1.94M | 0.00 | |
| NetPPEPurchaseAndSale | -287.53K | -210.60K | -606.19K |
| PurchaseOfPPE | -287.53K | -210.60K | -606.19K |
| OperatingCashFlow | 425.89K | 295.43K | 2.43M |
| CashFlowFromContinuingOperatingActivities | 425.89K | 295.43K | 2.43M |
| ChangeInWorkingCapital | -1.16M | -943.05K | 2.50M |
| ChangeInOtherWorkingCapital | -1.06M | -1.11M | 2.64M |
| ChangeInPayablesAndAccruedExpense | -102.60K | 329.53K | 180.40K |
| ChangeInPayable | -102.60K | 329.53K | 180.40K |
| ChangeInAccountPayable | -204.69K | 210.28K | 180.40K |
| ChangeInTaxPayable | 102.08K | 119.25K | 0.00 |
| ChangeInIncomeTaxPayable | 102.08K | 119.25K | 0.00 |
| ChangeInPrepaidAssets | 42.08K | -39.27K | -113.83K |
| ChangeInInventory | 1.35K | 38.18K | -55.87K |
| ChangeInReceivables | -44.29K | -164.98K | -154.02K |
| ChangesInAccountReceivables | -44.29K | -164.98K | -154.02K |
| OtherNonCashItems | -8.27K | -37.45K | 60.90K |
| UnrealizedGainLossOnInvestmentSecurities | -2.62K | 0.00 | |
| DeferredTax | 134.87K | 62.48K | |
| DeferredIncomeTax | 134.87K | 62.48K | |
| DepreciationAmortizationDepletion | 263.45K | 391.70K | 211.08K |
| DepreciationAndAmortization | 263.45K | 391.70K | 211.08K |
| Depreciation | 263.45K | 391.70K | 211.08K |
| NetIncomeFromContinuingOperations | 1.20M | 821.74K | -335.61K |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MCTA
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|